Showing results (811-820 of 942) with videos related to

Sort By:
Pageof 95
Circulation|January 24, 2024
Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With Atrial FibrillationSiddharth M Patel, Eugene Braunwald, Jan Steffel, et al.
Trials|August 15, 2022
Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21A Morrow, Stuart R Gray, H K Bayes, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2015
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase InhibitionMatthew J Fell, Christian Mirescu, Kallol Basu, et al.
European Heart Journal|May 21, 2023
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HFMuthiah Vaduganathan, Robert J Mentz, Brian L Claggett, et al.
Circulation. Cardiovascular Quality and Outcomes|April 5, 2023
Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease RegistryEric J Hall, Colby R Ayers, Ahmed A Kolkailah, et al.
Diabetes Care|September 18, 2021
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With DiabetesDavid D Berg, Stephen D Wiviott, Benjamin M Scirica, et al.
JAMA Cardiology|June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical TrialKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
European Journal of Heart Failure|December 3, 2020
Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium-glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58Thomas A Zelniker, David A Morrow, Ofri Mosenzon, et al.
Paediatric and Perinatal Epidemiology|October 16, 2012
Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program studyWilliam V Bobo, Robert L Davis, Sengwee Toh, et al.
European Heart Journal. Acute Cardiovascular Care|May 30, 2024
Targeted proteomic profiling of cardiogenic shock in the cardiac intensive care unitSiddharth M Patel, Mathew S Lopes, David A Morrow, et al.
Pageof 95